This approach examined whether there was a reverse causal relationship between urinary stones and circulating lipids (TG, LDL-C, HDL-C, APOA, APOB, and Pure hypercholesterolaemia) along with lipid-lowering drugs (HMGCR inhibitors and PCSK9 inhibitors). The gene discussed is PCSK9; the disease is Hypercholesterolemia.